MARY SMOCK: Open Payments
NPI 1639665698 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 96 payments from 26 companies in 2025. Trend: 2023 $1,578 · 2024 $1,820 · 2025 $2,050
Food & beverage: $2,040Education: $10
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $441 |
| Novo Nordisk Inc | 18 | $387 |
| Lilly USA, LLC | 9 | $162 |
| Amneal Pharmaceuticals LLC | 11 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| CeQur Corporation | 1 | $95 |
| Dexcom, Inc. | 3 | $64 |
| Tandem Diabetes Care, Inc. | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Madrigal Pharmaceuticals | 2 | $56 |
Products named: Ozempic, TEPEZZA, UNITHROID, MOUNJARO, LEQVIO, CeQur Simplicity, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
